Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Taylor, W. J.
Right arrow Articles by Rajapaske, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, W. J.
Right arrow Articles by Rajapaske, C. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 1100-1105, Copyright © 1997 by British Society for Rheumatology


ORIGINAL PAPERS

A retrospective review of yttrium-90 synovectomy in the treatment of knee arthritis

WJ Taylor, MM Corkill and CN Rajapaske
Wellington Regional Rheumatology Unit, Hutt Hospital, Hutt Valley Health Corporation Ltd, Lower Hutt, New Zealand.

We reviewed the case notes and X-rays of all patients with knee arthritis treated with yttrium-90 for the first time at a single institution from November 1981 to November 1995. Outcomes were assessed as 'improved' or 'not improved' by review of the case notes at 3, 6 and 12 months, and by the absence of further intra-articular (IA) steroid injections. Of the 121 knees treated, 87 had adequate follow-up information to allow an assessment of outcomes. Overall, 46% (95% CI 36- 57) were improved at 12 months and 37% (95% CI 27-47) had no further IA injections (mean follow-up of 3.5 yr). Knees with osteoarthritis (OA) fared significantly worse with 10% (95% CI 0-29) vs 51% (95% CI 39-63) improved at 12 months (P < 0.05). Knees younger than 30 appeared to do better with 78% (95% CI 51-100) vs 28% (95% CI 17-45) having no further IA injections (P < 0.02). Knees with normal X-rays (Kellgren grade 0-1) did significantly better than those with more severe radiographic abnormalities (Kellgren grade 3-4), with 56% (95% CI 40-73) vs 24% (95% CI 8-40) improved (P < 0.01). Radiosynovectomy with yttrium-90 for knee arthritis appears to be of less value for patients with OA or with secondary OA changes on X-ray, and may be of more value for younger patients and those with spondyloarthropathies.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
R. Klett, U. Lange, H. Haas, M. Voth, and J. Pinkert
Radiosynoviorthesis of medium-sized joints with rhenium-186-sulphide colloid: a review of the literature
Rheumatology, October 1, 2007; 46(10): 1531 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
W. U. Kampen, M. Voth, J. Pinkert, and A. Krause
Therapeutic status of radiosynoviorthesis of the knee with yttrium [90Y] colloid in rheumatoid arthritis and related indications
Rheumatology, January 1, 2007; 46(1): 16 - 24.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. Hasso, P. J. Maddison, and A. Breslin
Intra-articular methotrexate in knee synovitis
Rheumatology, June 1, 2004; 43(6): 779 - 782.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J Ailland, W U Kampen, M Schunke, J Trentmann, and B Kurz
{beta} Irradiation decreases collagen type II synthesis and increases nitric oxide production and cell death in articular chondrocytes
Ann Rheum Dis, November 1, 2003; 62(11): 1054 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M N Berliner, R G Bretzel, and R Klett
Successful radiosynoviorthesis of an olecranon bursitis in psoriatic arthritis
Ann Rheum Dis, February 1, 2002; 61(2): 187 - 188.
[Full Text] [PDF]


Home page
RadiologyHome page
H. Palmedo, J. K. Rockstroh, M. Bangard, K. Schliefer, J. Risse, C. Menzel, and H.-J. Biersack
Painful Multifocal Arthritis: Therapy with Rhenium 186 Hydroxyethylidenedi-phosphonate (186Re HEDP) after Failed Treatment with medication 3Initial Results of a Prospective Study
Radiology, October 1, 2001; 221(1): 256 - 260.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.